Clinical Trial

Validation of the Behavioral Activation for Depression Scale in Individuals With Substance Use Disorders

Study acronym: BADS-SUD
Completed
View on ClinicalTrials.gov →
Summary
This observational study evaluates the psychometric properties of the Behavioral Activation for Depression Scale (BADS) in individuals with substance use disorders. The study examines the scale's internal structure, reliability, and validity using data from 289 participants who completed the BADS. External and incremental validity analyses were conducted in a subsample of 127 participants for whom additional clinical measures were available, including assessments of symptom severity, anxiety, impulsivity, and anger expression. This approach reflects the availability of complete data for each analytic component and allows for a comprehensive evaluation of the BADS in a clinical population.
Trial Details
NCT Number NCT07395700
Lead Sponsor Lauro Gutiérrez Castro
Conditions Substance Use Disorders, Mental Health Disorders, Substance-related Disorders, Depression Scale Score, Validation Study
Enrollment 289 participants
Start Date 2024-03-18
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2026-02-09